Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.165 USD | -5.28% | -0.42% | -32.87% |
May. 10 | Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024 | |
May. 10 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.87% | 90.18M | |
+53.47% | 63.85B | |
-2.18% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.27% | 26.52B | |
-21.40% | 18.69B | |
+2.89% | 12.73B | |
+22.68% | 12.11B | |
+27.31% | 12.07B |
- Stock Market
- Equities
- PLX Stock
- News Protalix BioTherapeutics, Inc.
- HC Wainwright Adjusts Protalix BioTherapeutics' Price Target to $10 From $7, Keeps Buy Rating